ATE232867T1 - Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen - Google Patents
Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungenInfo
- Publication number
- ATE232867T1 ATE232867T1 AT96911227T AT96911227T ATE232867T1 AT E232867 T1 ATE232867 T1 AT E232867T1 AT 96911227 T AT96911227 T AT 96911227T AT 96911227 T AT96911227 T AT 96911227T AT E232867 T1 ATE232867 T1 AT E232867T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- tetronsic
- hiv
- pct
- acid derivatives
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 241001430294 unidentified retrovirus Species 0.000 title abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 229920002359 Tetronic® Polymers 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40732295A | 1995-03-20 | 1995-03-20 | |
| PCT/US1996/002680 WO1996029333A1 (en) | 1995-03-20 | 1996-03-07 | Substituted tetronic acids useful for treating hiv and other retroviruses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE232867T1 true ATE232867T1 (de) | 2003-03-15 |
Family
ID=23611540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96911227T ATE232867T1 (de) | 1995-03-20 | 1996-03-07 | Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6060600A (de) |
| EP (1) | EP0817786B1 (de) |
| JP (1) | JPH11503416A (de) |
| AT (1) | ATE232867T1 (de) |
| AU (1) | AU5417696A (de) |
| DE (1) | DE69626276T2 (de) |
| DK (1) | DK0817786T3 (de) |
| ES (1) | ES2191095T3 (de) |
| PT (1) | PT817786E (de) |
| SI (1) | SI0817786T1 (de) |
| WO (1) | WO1996029333A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9603097D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline compounds |
| JP3726684B2 (ja) * | 2001-01-11 | 2005-12-14 | 株式会社Ｋｄｄｉ研究所 | 動画像データ転送における輻輳を回避する通信システム |
| DE102006039912A1 (de) * | 2006-08-25 | 2008-03-20 | Bayer Healthcare Ag | Substituierte Spirotetronsäuren und ihre Verwendung |
| DE102006059319A1 (de) * | 2006-12-15 | 2008-06-19 | Bayer Healthcare Ag | Substituierte Aminofuranone und ihre Verwendung |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA852614B (en) * | 1985-05-17 | 1986-10-09 | Takeda Chemical Industries, Ltd. | Ascorbic acid ethers and their production |
| JP2515556B2 (ja) * | 1986-08-29 | 1996-07-10 | 武田薬品工業株式会社 | ヒドロキシブテノライド誘導体およびその製造法 |
| ES2052020T3 (es) * | 1988-10-20 | 1994-07-01 | Shionogi & Co | Antibioticos efectivos frente a bacterias anaerobias, su produccion y utilizacion y cepas de enterobacter productoras de los mismos. |
| JP3156006B2 (ja) * | 1990-07-30 | 2001-04-16 | 武田薬品工業株式会社 | テトロン酸誘導体、その製造法及び用途 |
| EP0480624A1 (de) * | 1990-10-11 | 1992-04-15 | Merck & Co. Inc. | HIV Protease Hemmstoffe |
| AU2267992A (en) * | 1991-08-27 | 1993-03-16 | Upjohn Company, The | Compounds used for the inhibition of hiv-protease |
| DE69226487T2 (de) * | 1991-09-26 | 1999-02-18 | Nippon Zoki Pharmaceutical Co., Ltd., Osaka | Verwendung von Furanonderivaten zur Vorbeugung oder Behandlung von Autoimmunkrankheiten |
| ZA938019B (en) * | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
| IL108459A0 (en) * | 1993-02-05 | 1994-04-12 | Opjohn Company | 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses |
| CA2168757A1 (en) * | 1993-09-17 | 1995-03-23 | Robert A. Chrusciel | Substituted tetronic acids useful for treating hiv and other retroviruses |
-
1996
- 1996-03-07 DE DE69626276T patent/DE69626276T2/de not_active Expired - Fee Related
- 1996-03-07 AT AT96911227T patent/ATE232867T1/de not_active IP Right Cessation
- 1996-03-07 PT PT96911227T patent/PT817786E/pt unknown
- 1996-03-07 DK DK96911227T patent/DK0817786T3/da active
- 1996-03-07 EP EP96911227A patent/EP0817786B1/de not_active Expired - Lifetime
- 1996-03-07 US US08/913,463 patent/US6060600A/en not_active Expired - Fee Related
- 1996-03-07 JP JP8528429A patent/JPH11503416A/ja not_active Ceased
- 1996-03-07 SI SI9630581T patent/SI0817786T1/xx unknown
- 1996-03-07 ES ES96911227T patent/ES2191095T3/es not_active Expired - Lifetime
- 1996-03-07 WO PCT/US1996/002680 patent/WO1996029333A1/en not_active Ceased
- 1996-03-07 AU AU54176/96A patent/AU5417696A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE69626276D1 (de) | 2003-03-27 |
| PT817786E (pt) | 2003-06-30 |
| US6060600A (en) | 2000-05-09 |
| EP0817786B1 (de) | 2003-02-19 |
| DK0817786T3 (da) | 2003-05-26 |
| AU5417696A (en) | 1996-10-08 |
| SI0817786T1 (en) | 2003-08-31 |
| ES2191095T3 (es) | 2003-09-01 |
| JPH11503416A (ja) | 1999-03-26 |
| WO1996029333A1 (en) | 1996-09-26 |
| DE69626276T2 (de) | 2003-11-13 |
| EP0817786A1 (de) | 1998-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE03969B1 (et) | (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid | |
| ATE262336T1 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
| EA200100524A1 (ru) | Амиды антраниловой кислоты и их применение в качестве лекарственных средств | |
| ATE230757T1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
| NO995006D0 (no) | Nye forbindelser | |
| DE3772429D1 (de) | Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten. | |
| DE69526937D1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
| ES2119185T3 (es) | Tratamiento de enfermedades micobacterianas por administracion de productos de la proteina bactericida/que aumenta la permeabilidad. | |
| ATE78696T1 (de) | Arzneimittelzubereitung zur behandlung des immunmangels. | |
| BR9509975A (pt) | Formulação farmacêutica | |
| ES2132383T3 (es) | Inhibidores de proteasa hiv. | |
| ATE217191T1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
| ATE232867T1 (de) | Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen | |
| ATE223721T1 (de) | Edelfosin zur behandlung von hirntumoren | |
| DE69522702D1 (de) | Eine lagerstabile wässrige lösung zur infusion die einen thrombininhibitor enthält | |
| DE69329687D1 (de) | Verwendung von aspirin zur herstellung eines arzneimittels zur verbesserung fer blutperfusion des uterus | |
| CY1106155T1 (el) | Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους | |
| DE69838980D1 (de) | Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen | |
| BG102404A (en) | The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system | |
| DE69230790D1 (de) | Arzneimittel zur Behandlung von durch Babesia verursachten Protozoeninfektionen | |
| SE9402241L (sv) | Inhibitor | |
| ES2137665T3 (es) | Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos. | |
| DE68903930D1 (de) | Lipidemulsion zur behandlung von aids. | |
| ATE67931T1 (de) | Butylhydroxyanisole zur behandlung von retrovirus-krankheiten. | |
| SE9404438D0 (sv) | New process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0817786 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |